Your AI-Trained Oncology Knowledge Connection!

Nico Van Zandwijk, MD, PhD

home / authors / nico-van-zandwijk-md-phd

Articles

The Role of Prognostic Factors and Oncogenes in the Detection and Management of Non-Small-Cell Lung Cancer

January 2nd 1998

Like other epithelial tumors, non-small-cell lung cancer (NSCLC) is a result of a series of genetic and epigenetic changes that eventually progress to invasive cancer. The order and timing of these changes, involving specific

Cisplatin/Paclitaxel vs Cisplatin/Teniposide for Advanced Non-Small-Cell Lung Cancer

Giuseppe Giaccone, MD, PhD;Pieter E. Postmus, MD, PhD;Ted A. W. Splinter, MD;Maria Diaz-puente, MD;Nico Van Zandwijk, MD, PhD;Giorgio V. Scagliotti, MD, PhD;Andrea Ardizzoni, MD;Jan Van Meerbeeck, MD;Channa Debruyne, MD;Tarek Sahmoud, MD

April 1st 1997

A total of 332 patients with advanced non-small-cell lung cancer were randomized by the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative